Innovative Partnership to Deliver Convenient Contraceptives to up to Three Million Women

Innovative Partnership to Deliver Convenient Contraceptives to up to Three Million Women

English
4 Pages
Read
Download
Downloading requires you to have access to the YouScribe library
Learn all about the services we offer

Description

Innovative Partnership to Deliver Convenient Contraceptives to up to Three Million Women PR Newswire LONDON, July 11, 2012 - Three-month contraceptive with novel injection device to be made available in up to six countries in sub-Saharan Africa and South Asia LONDON, July 11, 2012 /PRNewswire/ -- Public and private partners today announced plans to collaborate to reach approximately three million women in sub-Saharan Africa and South Asia from 2013-2016 with up to 12 million doses of an injectable contraceptive at affordable price levels. The partnership includes the UK's Department for International Development (DFID), the U.S. Agency for International Development (USAID), the United Nations Population Fund (UNFPA), Pfizer, PATH, and the Bill & Melinda Gates Foundation. Initial countries interested in taking part include Senegal and Nigeria. The announcement, made today at the London Summit on Family Planning, is part of a new, coordinated effort to ensure that voluntary family planning services reach an additional 120 million women and girls in the world's poorest countries by 2020. More than 150 leaders from donor and developing countries, international agencies, civil society, foundations and the private sector also pledged their support to improving access to family planning information, services and supplies.

Subjects

Informations

Published by
Reads 33
Language English
Report a problem
Innovative Partnership to Deliver Convenient
Contraceptives to up to Three Million Women
PR Newswire
LONDON, July 11, 2012
- Three-month contraceptive with novel injection device to be made available in
up to six countries in sub-Saharan Africa and South Asia
LONDON
,
July 11, 2012
/PRNewswire/ -- Public and private partners today
announced plans to collaborate to reach approximately three million women in
sub-Saharan Africa and
South Asia
from 2013-2016 with up to 12 million doses
of an injectable contraceptive at affordable price levels. The partnership
includes the UK's Department for International Development (DFID), the U.S.
Agency for International Development (USAID), the United Nations Population
Fund (UNFPA), Pfizer, PATH, and the Bill & Melinda Gates Foundation. Initial
countries interested in taking part include
Senegal
and
Nigeria
.
The announcement, made today at the London Summit on Family Planning, is
part of a new, coordinated effort to ensure that voluntary family planning
services reach an additional 120 million women and girls in the world's poorest
countries by 2020. More than 150 leaders from donor and developing
countries, international agencies, civil society, foundations and the private
sector also pledged their support to improving access to family planning
information, services and supplies.
"Working with local partners in
Africa
and
South Asia
, we have learned that
many women want to use injectable contraceptives but simply cannot get
access to them," said PATH President and CEO Steve Davis. "This program,
including PATH's field studies, will ensure effective family planning tools reach
women who need them while saving women valuable time and resources that it
would otherwise take to reach a clinic."
The product prevents pregnancy for three months with a single injection using
the pre-filled, auto-disable Uniject™ device. In addition to delivering the
product, partners are planning to provide complementary family planning
information and services to help expand choice and access for the poorest
women and hard to reach communities.
"Every woman, no matter how rich or poor, should have access to her
preferred method of contraception to determine the number and timing of her
children," said Chris Elias, president of Global Development at the Bill & Melinda
Gates Foundation. "This innovative partnership will bring modern contraceptive
technology to women living in some of the world's most remote regions."
Injectable contraception is a popular form of contraception among women in
developing countries. In some places, women must return to a clinic every
three months for a new injection from a skilled health worker, or to a health
post to be served by a community health worker, limiting access in remote and
other hard to reach areas. The proposed contraceptive's unique delivery
system makes it more portable than many other options, allowing injections to
be provided by health workers to women at home or in other convenient
settings.
The contraceptive product combines a reformulation of Pfizer's Depo-Provera®
(medroxyprogesterone acetate) contraceptive with the Uniject injection system,
originally developed by PATH with support from USAID, which allows the
contraceptive to be administered via subcutaneous injection.[1]
Under the partnership, Pfizer is currently seeking approval from the relevant
authorities in European and African states. Subject to these approvals, the
product could be registered and available in initial countries in sub-Saharan
Africa by mid-2013.
Enrico Liggeri, Pfizer's Country Lead,
Nigeria
, East Africa Regions, said: "Pfizer is
committed to increasing access in developing countries to its portfolio of
reproductive health products. While the industry can take the lead in
developing products suited to the needs of the market, it is largely through
innovative Private Public Partnerships instead of donations alone that we can
ensure the long term viability of the supply and distribution, and at the same
time the sustainability of education toward healthier reproductive lifestyles."
Research is currently underway that is expected to inform the rollout, including
studies to better understand women's and providers' acceptability of the
product. The research will also provide important guidance for the introduction
of the method at country, community, facility, and local levels including training
on counseling and injection delivery, delivery logistics, and waste management.
"Access to modern contraception is crucial to helping the millions of poor
women who want to be able to decide when, whether and how many children
to have.
Britain
is working with the private sector to find innovative solutions
that will enable women to make the decisions about their families which many
of us take for granted," said Andrew Mitchell, Secretary of State for the UK's
Department for International Development.
"USAID provided more than 15 years of technical oversight and funding support
to advance this technology," noted USAID Administrator Rajiv Shah. "This
product is one of a number that we are supporting that expand contraceptive
method choice, respond to women's needs, and help make methods more
accessible to more than 200 million women in the poorest countries of the
world who lack adequate access to contraceptives."
For more information on the introduction of this product, visit
http://www.path.org/projects/uniject-dmpa.php
Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates
Foundation works to help all people lead healthy, productive lives. In developing
countries, it focuses on improving people's health and giving them the chance
to lift themselves out of hunger and extreme poverty. In
the United States
, it
seeks to ensure that all people—especially those with the fewest resources—
have access to the opportunities they need to succeed in school and life. Based
in
Seattle, Washington
, the foundation is led by CEO Jeff Raikes and Co-chair
William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren
Buffett.
For further information please contact: media@gatesfoundation.org
UK Department for International Development (DFID)
The Department for International Development (DFID) leads the UK
government's effort to fight global poverty. DFID's overall aim is to reduce
poverty in poorer countries, in particular through achieving the Millennium
Development Goals (MDGs). This will be done by honouring the UK's
international commitments; making British aid more effective by improving
transparency and value for money; leading international action to improve the
lives of girls and women; strengthening governance and security in fragile and
conflict-affected countries; boosting wealth creation; and driving urgent action
to tackle climate change.
For further information please contact the DFID press office: +44-020-7023-
0600
US Agency for International Development (USAID)
The U.S. Agency for International Development (USAID) oversees and
implements international development programs for the U.S. government.
USAID's work in development joins diplomacy and defense as one of three key
pieces of the nation's foreign policy apparatus. USAID promotes peace and
stability by fostering economic growth, protecting human health, providing
emergency humanitarian assistance, and enhancing democracy in developing
countries. These efforts to improve the lives of millions of people worldwide
represent U.S. values and advance U.S. interests for peace and prosperity.
USAID provides assistance in sub- Saharan Africa,
Asia
and the Near East,
Latin
America
and the
Caribbean
, and
Europe
and Eurasia. With headquarters in
Washington, D.C.
, USAID's strength is its field offices in many regions of the
world.
USAID media relations:
Nicole Schiegg
Phone: +1-202-712-1706
Email: nschiegg@usaid.gov
United Nations Population Fund (UNFPA)
UNFPA, the United Nations Population Fund, is an international development
agency that promotes the right of every woman, man and child to enjoy a life
of health and equal opportunity. UNFPA supports countries in using population
data for policies and programmes to reduce poverty and to ensure that every
pregnancy is wanted, every birth is safe, every young person is free of
HIV/AIDS, and every girl and woman is treated with dignity and respect.
UNFPA media relations:
Omar Gharzeddine
Phone: +1-212-297-5028
Email: gharzeddine@unfpa.org
Pfizer Inc.: Working together for a healthier world™
At Pfizer, we apply science and our global resources to improve health and
well-being at every stage of life. We strive to set the standard for quality, safety
and value in the discovery, development and manufacturing of medicines for
people and animals. Our diversified global health care portfolio includes human
and animal biologic and small molecule medicines and vaccines, as well as
nutritional products and many of the world's best-known consumer products.
Every day, Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge the most
feared diseases of our time. Consistent with our responsibility as the world's
leading biopharmaceutical company, we also collaborate with health care
providers, governments and local communities to support and expand access
to reliable, affordable health care around the world. For more than 150 years,
Pfizer has worked to make a difference for all who rely on us.
Pfizer media relations:
Andrew Widger Director, Media Relations Europe,
Middle East
,
Africa
Mobile: +44797-0149098
Direct Line: +441737-330909
PATH
PATH is an international nonprofit organization that transforms global health
through innovation. PATH takes an entrepreneurial approach to developing and
delivering high-impact, low-cost solutions, from lifesaving vaccines and devices
to collaborative programs with communities. Through its work in more than 70
countries, PATH and its partners empower people to achieve their full potential.
For more information, please visit www.path.org
PATH media relations:
Amy MacIver, Director of Media Relations
Phone: +1-206-302-4522
Email: media@path.org
[1] Depo-Provera is an intramuscular contraception. This reformulation and
device delivers the contraceptive subcutaneously.